KPRX
Price
$2.80
Change
+$0.07 (+2.56%)
Updated
Sep 3 closing price
Capitalization
9.61M
TNXP
Price
$27.70
Change
+$0.04 (+0.14%)
Updated
Sep 3 closing price
Capitalization
242.82M
67 days until earnings call
Interact to see
Advertisement

KPRX vs TNXP

Header iconKPRX vs TNXP Comparison
Open Charts KPRX vs TNXPBanner chart's image
Kiora Pharmaceuticals
Price$2.80
Change+$0.07 (+2.56%)
Volume$81.08K
Capitalization9.61M
Tonix Pharmaceuticals Holding
Price$27.70
Change+$0.04 (+0.14%)
Volume$1.15M
Capitalization242.82M
KPRX vs TNXP Comparison Chart in %
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. TNXP commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a Buy and TNXP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (KPRX: $2.73 vs. TNXP: $27.66)
Brand notoriety: KPRX and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 69% vs. TNXP: 60%
Market capitalization -- KPRX: $9.61M vs. TNXP: $242.82M
KPRX [@Biotechnology] is valued at $9.61M. TNXP’s [@Biotechnology] market capitalization is $242.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 2 FA rating(s) are green whileTNXP’s FA Score has 1 green FA rating(s).

  • KPRX’s FA Score: 2 green, 3 red.
  • TNXP’s FA Score: 1 green, 4 red.
According to our system of comparison, KPRX is a better buy in the long-term than TNXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 3 TA indicator(s) are bullish while TNXP’s TA Score has 4 bullish TA indicator(s).

  • KPRX’s TA Score: 3 bullish, 6 bearish.
  • TNXP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TNXP is a better buy in the short-term than KPRX.

Price Growth

KPRX (@Biotechnology) experienced а -3.91% price change this week, while TNXP (@Biotechnology) price change was -18.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

TNXP is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($243M) has a higher market cap than KPRX($9.61M). KPRX has higher P/E ratio than TNXP: KPRX (3.67) vs TNXP (0.01). TNXP YTD gains are higher at: -16.131 vs. KPRX (-17.273). KPRX has higher annual earnings (EBITDA): -9.41M vs. TNXP (-75.85M). TNXP has more cash in the bank: 125M vs. KPRX (20.7M). KPRX has less debt than TNXP: KPRX (430K) vs TNXP (492K). TNXP has higher revenues than KPRX: TNXP (9.83M) vs KPRX (0).
KPRXTNXPKPRX / TNXP
Capitalization9.61M243M4%
EBITDA-9.41M-75.85M12%
Gain YTD-17.273-16.131107%
P/E Ratio3.670.0133,618%
Revenue09.83M-
Total Cash20.7M125M17%
Total Debt430K492K87%
FUNDAMENTALS RATINGS
KPRX vs TNXP: Fundamental Ratings
KPRX
TNXP
OUTLOOK RATING
1..100
1654
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6238
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5019

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (20) in the Pharmaceuticals Other industry is in the same range as TNXP (22). This means that KPRX’s stock grew similarly to TNXP’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TNXP (100). This means that KPRX’s stock grew similarly to TNXP’s over the last 12 months.

KPRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as TNXP (98). This means that KPRX’s stock grew similarly to TNXP’s over the last 12 months.

TNXP's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as KPRX (62). This means that TNXP’s stock grew similarly to KPRX’s over the last 12 months.

KPRX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for TNXP (100). This means that KPRX’s stock grew significantly faster than TNXP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXTNXP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 22 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXU8.410.09
+1.08%
LSB Industries
SEED1.180.01
+0.60%
Origin Agritech Limited
GWRE217.460.44
+0.20%
Guidewire Software
SPRO2.05-0.02
-0.97%
Spero Therapeutics
BATRA46.53-0.98
-2.05%
Atlanta Braves Holdings

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if KPRX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-1.80%
NCNA - KPRX
90%
Closely correlated
-6.58%
RNAC - KPRX
89%
Closely correlated
-2.09%
NBY - KPRX
89%
Closely correlated
+28.09%
ALLR - KPRX
86%
Closely correlated
+3.90%
TNXP - KPRX
84%
Closely correlated
-6.65%
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-6.65%
NCNA - TNXP
90%
Closely correlated
-6.58%
TAOX - TNXP
88%
Closely correlated
+6.70%
RNAC - TNXP
88%
Closely correlated
-2.09%
CDTX - TNXP
87%
Closely correlated
-2.45%
NBY - TNXP
87%
Closely correlated
+28.09%
More